StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.56−0.19 (-0.38%)

Close on Nov 18, 2026Market cap $10.75BP/E 25.5Yield 0.50%

Qiagen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $2.09B, up 5.7% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $2.25B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.09B+5.7%
FY2024Dec 31, 2024$1.98B+0.7%
FY2023Dec 31, 2023$1.97B-8.2%
FY2022Dec 31, 2022$2.14B-4.9%
FY2021Dec 31, 2021$2.25B+20.4%
FY2020Dec 31, 2020$1.87B+22.5%
FY2019Dec 31, 2019$1.53B+1.6%
FY2018Dec 31, 2018$1.50B+5.9%
FY2017Dec 31, 2017$1.42B+5.9%
FY2016Dec 31, 2016$1.34B+4.5%
FY2015Dec 31, 2015$1.28B-4.7%
FY2014Dec 31, 2014$1.34B+3.3%
FY2013Dec 31, 2013$1.30B+3.8%
FY2012Dec 31, 2012$1.25B+7.2%
FY2011Dec 31, 2011$1.17B+7.6%
FY2010Dec 31, 2010$1.09B+7.7%
FY2009Dec 31, 2009$1.01B+13.1%
FY2008Dec 31, 2008$892.98M–

More Qiagen figures

See a number that looks wrong?